Bank of America
CERO

Bank of America’s CERo Therapeutics CERO Stock Holding History

Bank of America’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3
Closed -$15 – 8483
2025
Q3 		$15 Buy
3
+1
+50% +$7 ﹤0.01% 8193
2025
Q2 		$19 Buy
2
+1
+100% +$12 ﹤0.01% 8250
2025
Q1 		$13 Buy
+1
New +$40 ﹤0.01% 8196
2024
Q4 		– Hold
0
– – – 7903
2024
Q3 		– Hold
0
– – – 7960
2024
Q2 		– Hold
0
– – – 8008

Bank of America's CERO Position: Q4 2025 in Review

Bank of America sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 3 shares — an estimated $15 sold.

Bank of America first reported a position in CERO in Q1 2025 and held it in 3 quarters. The position peaked at $19 in Q2 2025. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

  • Bank of America reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 3 CERo Therapeutics shares in Q4 2025, an estimated $15.
  • Bank of America first reported a position in CERo Therapeutics in Q1 2025 and held it in 3 quarters.
  • Bank of America's CERo Therapeutics position peaked at $19 in Q2 2025.
  • 0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.